RxDoctor Payments Data

Jesse Otero

Orthopaedic Surgery · Charlotte, NCNPI 1821381674

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (48.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 50.8% of the total. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$603,656in general payments, 2019–2025

Across 372 payments — averaging $1622.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$306K
  • Zimmer Biomet$201K
  • Medical Device Business Services, Inc.$80K
  • Onkos Surgical, Inc.$14K
  • Smith+Nephew$730
  • Johnson & Johnson$353
  • plus $2K from 13 others
$212,806in research payments, 2019–2025

Across 80 payments — averaging $2660.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$110K
  • Medical Device Business Services, Inc.$103K

What the payments were for

  • Royalty or licence$294,50449%
  • Consulting fees$195,82232%
  • Travel & lodging$21,9614%
  • Food & beverage$10,2342%
  • Education$81,13613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$603,656 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$325,863
Medicare patients
439
Services billed
1,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam117$262
Oxycodone Hcl25$171
Pregabalin12$119
Methylprednisolone23$115
Tramadol Hcl35$90
Amoxicillin55$63
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$50
Clindamycin Hcl12$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →